Foluke O. G.
Olorundare
a,
Dimpo S.
Sipuka
ac,
Tsholofelo I.
Sebokolodi
ac,
Tetsuya
Kodama
b,
Omotayo A.
Arotiba
*ac and
Duduzile
Nkosi
*ac
aDepartment of Chemical Sciences, University of Johannesburg, Doornfontein 2028, Johannesburg, South Africa. E-mail: oarotiba@uj.ac.za; dnkosi@uj.ac.za
bLaboratory of Biomedical Engineering for Cancer, Graduate School of Biomedical Engineering, Tohoku University, 4-1 Seiryo, Aoba, Sendai, Miyagi 980-8575, Japan
cCentre for Nanomaterials Science Research, University of Johannesburg, South Africa
First published on 30th June 2023
The early detection of cancer is a key step in cancer survival. Thus, there is a need to develop low-cost technologies, such as electrochemical immunosensor technologies, for timely screening and diagnostics. The discovery of alpha-feto protein (AFP) as a tumour-associated antigen lends AFP as a biomarker for cancer detection and monitoring. Thus, immunosensors can be developed to target AFP in cancer diagnostics. Hence, we report the application of a hybrid nanocomposite of carbon black nanoparticles (CBNPs) and palladium nanoparticles (PdNPs) as a platform for the electrochemical immunosensing of cancer biomarkers. The hybrid carbon–metal nanomaterials were immobilised by using the drop-drying and electrodeposition technique on a glassy carbon electrode, followed by the immobilisation of the anti-AFP to fabricate an immunosensor. The nanoparticles were characterised with electron microscopy, voltammetry, and electrochemical impedance spectroscopy (EIS). Square wave voltammetry (SWV) and EIS were used to study the immunosensor signal toward the bio-recognition of the AFP cancer biomarker. The hybrid nanoparticles enhanced the immunosensor performance. A linear detection range from 0.005 to 1000 ng mL−1 with low detection limits of 0.0039 ng mL−1 and 0.0131 ng mL−1 were calculated for SWV and EIS, respectively. The immunosensor demonstrated good stability, reproducibility, and selectivity. Its real-life application potential was tested with detection in human serum matrix.
The discovery of biomarkers has been beneficial to cancer detection and monitoring.6 Some biomarkers are indicators of the occurrences of different types of cancer.5,7 For example, alpha-fetoprotein (AFP), is a glycoprotein synthesized by the fetal yolk sac and liver cells. AFP can be used to identify and predict certain types of tumours, such as teratoma endoderm, testicular cancer, ovarian cancer, squamous cell carcinoma of the cervix, yolk sac cancer, gastric cancer and hepatocellular cancer.8,9 An increase in the concentration of AFP over 25 ng mL−1 can be an indication of cancer.7,10,11 For the detection of AFP, methods such as chemiluminescent immunoassay (CLI),12 enzyme-linked immunoassay (ELISA),13 fluorescence immunoassay (FI),14 electrochemiluminescence (ECL) immunoassay,15 and surface plasmon resonance (SPR) immunoassay,16 have emerged. Although the aforementioned methods have good sensitivity, they are usually expensive with complicated processes and have extensive analysis times. In comparison with these methods, electrochemical immunosensor technologies for the detection of cancer biomolecules or analytes have many advantages, such as low cost, high sensitivity, portability, negligible sample requirement, and the ease of operation.17–19 In this light, electrochemical immunosensors are studied for cancer diagnostics.
Generally, electrochemical immunosensors can be labelled20,21 or label free.22,23 Electrochemical immunosensors based on label-free strategies have captivated attention in the detection of AFP, owing to its ease of preparation, ease of detection, simplicity, very good accuracy, chemical stability, low cost and high biocompatibility.24 In label-free immunosensors, signal enhancement strategies, such as the use of a hybrid electroactive and conductive nanomaterials as immobilisation layer for the bioreceptor–analyte biorecognition (antibody–antigen immunocomplex formation), are critical in obtaining low detection limits and augmenting the sensitivity of electrochemical immunosensor assays. Recently, different materials or composites have been reported to amplify the signal and enhance the sensitivity of electrochemical immunosensors for AFP detection.25 For example, Wang et al.19 reported the development of a novel electrochemical immunosensor on functionalized graphene nanocomposites (TB–Au–Fe3O4–rGO) in order to achieve a higher signal amplification for the detection of AFP, and obtained 2.7 fg mL−1 as the detection limit.19 Furthermore, Wang et al.26 invented a unique electrochemical immunosensor platform using a Cu3PtNFs-catalysed oxygen reduction reaction (ORR) as signal amplification to detect AFP. A linear range of 0.1–104 pg mL−1 and a detection limit of 0.033 pg mL−1 was recorded. Using an aptamer, Upan et al.11 developed an aptasensor on a platinum and graphene oxide platform with a limit of detection in the nanogram per mL concentration.11
The reactivity of an electrochemical immunosensor is considerably influenced by the conductivity/sensitivity of the sensors surface. Thus, various nanomaterials (NMs) comprising carbon materials, metal nanoparticles, metal oxides, quantum dots and others have been employed to modify electrodes in order to boost the immunosensor signal or performance.27 Hybrid nanoparticles are particularly desirable due to their enhanced electrical properties, magnetic properties, optical properties, long-term stability, and chemical properties, which are superior to single-constituent nanoparticles.28 In this work, a hybrid platform of carbon black and palladium nanoparticles was used for the development of an immunosensor for the first time.
Carbon black nanoparticles (CBNPs) are carbonaceous nanomaterials that are used because of their properties, which include dispersibility, high conductivity, high surface area and low cost. In addition to their resistance to fouling, CBNPs have the advantages of increasing electron transfer, improving sensitivity, and reducing the applied potential for analyte quantification.29,30 They have also been found to be biocompatible owing to their low or non-toxicity.31 CBNPs are spherical nanoparticles with the basal planes oriented parallel to the surface, and are known to possess a high surface area.32 They also have surface groups with a high concentration of oxygen that may be involved in the covalent bonding to many biological receptors.29 Good chemical stability and the high surface area of CBNPs make them good carriers or supports for metal nanoparticles.30
Owing to the properties of CBNPs, they have found application in electrochemical sensors and biosensor. For instance, Ławrywianiec et al.33 utilized CBNPs to modify a glassy carbon electrode (GCE) for the detection of bisphenol A. The modified electrode significantly improved the oxidation peak current of bisphenol A compared with the bare GCE. A detection limit of 3.4 × 10−9 mol L−1 was obtained under optimum conditions.33 Mazzaracchio et al.28 reported on a fabricated electrochemical sensor based on CBNPs and a poly(propylene imine) (PPI) dendrimer on a screen-printed electrode (SPE) for the co-detection of lead and cadmium metallic ions in water. Low detection limits of 3.6 ppb and 15.3 ppb were obtained for the simultaneous detection of both metallic ions (lead and cadmium).28
The other material used in the hybrid immunosensor reported in this work is palladium nanoparticles (PdNPs). PdNPs have found application in electrochemical immunosensing nanotechnology development owing to their catalytic properties, good conductivity and high surface area.32 The incorporation of PdNPs in the fabrication of the electrode surface improves the electron transfer, and also lowers the detection limit.34 Furthermore, palladium-based metal nanoparticles with its excellent properties have been applied in the detection of cancer biomarkers, displaying properties such as ease of synthesis, diverse optical properties, and a range of adsorption sites for binding biological macromolecules, which are opened up for electrochemical immunosensing nanotechnology application.35 PdNPs have been used as a hybrid component in electrochemical detection. For example, Jain et al.36 fabricated an electrochemical biosensor for the detection of a neuromodulator level in biological samples using a hybrid of molybdenum disulfide nanostructures and PdNPs. In another work, a hybrid of a composite of PdNPs (as an electrocatalyst) with an amine-functionalized Cr-based organometallic framework (Pd/MIL101-NH2) was used for the detection of telomerase.37
The use of hybrids as an immobilisation layer in biosensor development brings together the favourable properties of each of the components usually in a synergetic manner. Nanohybrids are used to tailor and enrich the desired immobilisation chemistry. For example, in an aptasensor for the detection of bisphenol A on a hybrid of a poly (propylene imine) dendrimer–carbon nanofiber, the dendrimer was used for supramolecular attachment of the dendrimer, while the carbon nanofiber was used to improve the conductivity of the electrode.38 Mushiana et al.39 reported on an electrochemical aptasensor for arsenic on a hybrid of carbon and gold nanoparticles. The carbon nanoparticle was used as a nano-template for the uniform immobilisation of gold nanoparticles by electrodeposition, while the gold nanoparticle was used to anchor a thiolated aptamer onto the electrode surface through Au–S linkage.39 These two examples and others28,36,37,40 show that hybrids can be used to improve the performance and stability of an electrochemical biosensor by improving the following properties: bioreceptor immobilisation, surface area, conductivity, electrocatalysis etc.
In this study, we explore a synergic combination of CBNPs and PdNPs as a nanohybrid to develop an electrochemical immunosensor for the detection of AFP. The carbon black and palladium nanoparticles were deposited on GCE to improve the analytical performance of the immunosensor for the AFP biomarker detection. The developed platform performance and application to a human serum sample were also investigated.
The chemicals used were of analytical grade, and used without further purification. Ultrapure Millipore water was utilized for all of the chemical preparations throughout the experiments with a resistivity of 18.2 MΩ cm at 24.1 °C from Merck Millipore, South Africa. Phosphate-buffer saline (PBS) of pH 7.5 was applied as an electrolyte for all experimental measurements.
Palladium nanoparticles (PdNPs) were electrodeposited on the GCE/CBNPs from a 5 mM palladium chloride solution/electrolyte by running cyclic voltammetry (CV) from −0.3 V to 1.2 V for 20 cycles with continuous stirring with a magnetic stirrer at 200 rpm at 50 mV s−1 scan rate.34 The modified electrode was labelled PdNPs/CBNPs/GCE.
The preparation of the immunosensor was done by immobilising 20 μL of antibody solution of AFP (500 ng mL−1) on the GCE/CBNPs/PdNPs nanocomposite-modified electrode overnight at 4 °C, and subsequently blocked by 0.25% BSA for 4 h to avoid nonspecific binding at the electrode surface. The electrodes were labelled antibody/PdNPs/CBNPs/GCE and BSA/antibody/PdNPs/CBNPs/GCE, respectively. Scheme 1 shows the preparation pathway for the immunosensor.
![]() | ||
Fig. 1 FESEM micrographs of (A) CBNPs, (B) SPCE–CBNPs, (C) SPCE–PdNPs, (D) SPCE–CBNPs–PdNPs, and (E) EDS of CBNPs–PdNPs. TEM images of (F) CBNPs and (G) CBNPs/PdNPs. |
Modified electrodes | I pa (mA) | ΔE (mV) | R s (Ω) | R ct (Ω) | CPE (nF) |
---|---|---|---|---|---|
GCE | 0.02 | 410 | 120.5 | 3102 | 60.17 |
GCE/CBNPs | 0.23 | 120 | 93.84 | 139.1 | 15.94 |
GCE/CB/PdNPs | 0.32 | 75 | 62.16 | 5.777 | 40.16 |
GCE/CBNPs/PdNPs/antibody | 0.27 | 150 | 83.28 | 18.164 | 25.95 |
GCE/CBNPs/PdNPs/antibody/BSA | 0.05 | 160 | 77.59 | 44.76 | 10.48 |
The EIS (Fig. 2B) was fitted using a Randles equivalent circuit (Fig. 2B inset) consisting of solution resistance (Rs), Warburg impedance (Zw), charge transfer resistance (Rct), and double-layer capacitance (Cdl). The data derived from the equivalent circuit are listed in Table 1. The trend in the Rct values agrees with the result from CV: the lowest Rct (5.78 Ω) at CBNPs/PdNPs corroborates the highest current in Fig. 2B(c) (Table 1). Immobilisation of the AFP antibody on the modified electrode (Fig. 2B(d)) increased the Rct to 18.16 Ω (Table 1), and blocking with BSA (Fig. 2B(d)) resulted in a further increase in Rct to 44.76 Ω (Table 1). It is expected that the biomolecules – AFP and BSA – will block sites on the CBNPs/PdNPs, which will impede the flow of electrons. Of note is the marked change in Rct when the GCE/CBNPs is compared with the CBNPs/PdNPs platform. This change depicts a synergistic combination of the two nanoparticles, which brings about an increase in the rate of electron transfer and the surface area. These enhancements will be beneficial for the immunosensor readout. The bare GCE had the largest charge transfer resistance, as indicated in the Nyquist plot inset in Fig. 2B.
A linear regression equation of Y (A) = 2.3750x + 1.5940 and a correlation coefficient of (R2) = 0.9969 were obtained from the scan rate study of the CBNPs/PdNPs/antibodies/BSA (the immunosensor). The obtained linear relationship between the peak current and the square root of the scan rates shows that the kinetics of electron transfer is a diffusion-controlled process (plot not shown). The obtained linearity forms the premise for the quantification of AFP by the immunosensor.
![]() | ||
Fig. 3 Optimisation of the immunosensor in 100 ng per mL AFP antigen. (A) Incubation temperature from 20 °C to 50 °C. (B) Incubation time from 20 min to 70 min. |
The immunosensor was utilized in the analysis of various concentrations of the AFP antigen with SWV and EIS as interrogating tools. For SWV, an increase in the concentration of the antigen increases the amount of antigen bound to the antibody. The increase in the density of antigen–antibody immune-complex creates an insulating or blocking effect towards the approach of the redox probe, and thus decreases the amount of redox electron transport at the interface of the immunosensor and the redox probe in solution – this is a signal-off approach. The calibration curve (Fig. 4B inset) of the AFP concentration is linear (from 0.005 to 1000 ng mL−1), with a regression equation of Y (A) = 6.0109x + 6.3975 and a correlation coefficient of 0.9925. A good limit of detection of 0.0039 ng mL−1 was achieved for the SWV from , where SD is the standard deviation of the blank and the m is the gradient of the calibration curve.
The EIS measurement of the biorecognition between the antigen–antibody is a direct proportionality between Rct and the concentration of AFP with a linear AFP concentration range from 0.005 to 1000 ng mL−1. An average error of 6.5% (for Rct fitting), a regression equation of Y (Ω) = 39.0324x + 1.0846, a correlation coefficient of 0.9861 (Fig. 4C inset-linear fit) and a detection limit of 0.0131 ng mL−1 were obtained. The results demonstrate that the immunosensor showed excellent sensitivity towards the detection of AFP.
The limits of detections from SWV and EIS are of analytical significance since the minimum AFP concentration in the human body is expected to be about 25 ng mL−1. The fabricated immunosensor was compared to other immunosensors reported in the literature, and the methods for the detection used are highlighted in Table 2. The proposed immunosensor has a lower detection limit and a simple fabrication strategy in comparison to other immunosensors.
Immunosensor | Linear range (ng mL−1) | Detection limit | References |
---|---|---|---|
a (1) Gold nanorods GNRs, (2) hyperbranched polyester nanoparticles with nitrite groups/chitosan/gold nanoparticles (HBPE-NO2)/CS–Au, (3) carbon/gold bi-nanoparticles, CNPs/AuNPs, (4) gold nanoparticles/generation 3 poly(propylene imine) AuNPs/G3PPI, (5) three-dimensional ordered macroporous iridium oxides 3DOM IrOx, (6) gold nanoparticles/porous graphene nanoribbon AuNPs/PGNR, (7) platinum nanoparticles on carboxylated graphene oxide PtNPs/GO-COOH. | |||
1. GNRs | 0.1–200 ng mL−1 | 0.04 ng mL−1 | 41 |
2. (HBPE-NO2)/CS–Au | 0.1–120 ng mL−1 | 0.055 ng mL−1 (DPV) | 42 |
3. CNPs/AuNPs | 0.005–1000 ng mL−1 & 0.00175 ng mL−1 (EIS) | 0.0019 ng mL−1 (SWV) | 40 |
4. AuNPs/G3PPI | 0.005–500 ng mL−1 & 0.00185 ng mL−1 (EIS) | 0.0022 ng mL−1 (SWV) | 43 |
5. 3DOM IrOx | 1–250 ng mL−1 | 0.3 ng mL−1 (CV) | 24 |
6. AuNPs/PGNR | 5–60 ng mL−1 | 1 ng mL−1 (DPV) | 44 |
7. PtNPs/GO-COOH | 3.0–30 ng mL−1 | 1.22 ng mL−1 (DPV) | 11 |
8. CBNPs/PdNPs | 0.005–1000 ng mL−1 & 0.0131 ng mL−1 (EIS) | 0.0039 ng mL−1 (SWV) | Present work |
The selectivity study involves the use of different interference agents, such as HER2, CEA, PSA, urea, ascorbic acid, D-glucose, uric acid, and dopamine. The AFP antigen (10 ng mL−1) was incubated in the presence of interfering agents (Fig. 5C). The effect of all of the interfering agents on the immunosensor showed less than 12.5% interference, an indication of good selectivity.40,43,44
Serum sample number | Addition content (ng mL−1) | Amount detected (ng mL−1) | RSD (%, n = 6) | Recovery (%) |
---|---|---|---|---|
1 | 5.0 | 5.06, 5.05, 5.03, 4.99, 4.98 | 0.7603 | 100.5 |
2 | 50.0 | 49.90, 49.97, 50.00, 50.04, 50.03 | 0.1089 | 99.98 |
3 | 100.0 | 100.01, 99.91, 100.06, 100.05, 99.90 | 0.0778 | 99.99 |
This journal is © The Royal Society of Chemistry 2023 |